NeoTherma Oncology Inc.

Wichita, KS · Medtech · Private

VectRx™, a non-invasive medical device that delivers loco-regional mild hyperthermia to deep-seated abdominal tumors as adjuvant cancer therapy, integrated with microwave thermometer temperature monit

Grants
$1.4M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
6
2 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Quantifiable Thermal Therapy Using Magnetic Resonance Thermometry Imaging$299,014
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Quantifiable Thermal Therapy Using Magnetic Resonance Thermometry Imaging$299,014
Federal grantDepartment of Health and Human Services · Phase I · Integration of non-invasive deep tissue microwave thermometry in the VectRx hyperthermia device in a transgenic liver tumor pig model$399,999
Federal grantDepartment of Health and Human Services · Phase I · Integration of non-invasive deep tissue microwave thermometry in the VectRx hyperthermia device in a transgenic liver tumor pig model$399,999
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1610AROMHA, INC.—$425K
1611WR Biotech, LLC——
1612Buck Surgical, Inc.—$300K
1613NeoTherma Oncology Inc.——
1614VYLUMA INC.——
1615PEAK DIAGNOSTIC PARTNERS LLC——
1616Eye To Eye Telehealth, Inc.—$1.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 6

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.